CYTOMAB 100MG

Cytomab 100mg injection contains rituximab as its active ingredient and is utilized for treating various conditions in adults.
Cytomab 100mg can be given either alone or alongside other medications to address non-Hodgkin’s lymphoma (a cancer that affects B-lymphocytes) and chronic lymphocytic leukemia (a prevalent cancer of B-cells).
It is also approved for the treatment of moderate-to-severe rheumatoid arthritis, in conjunction with methotrexate, in adult patients.
Additional applications include the treatment of granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels impacting the lungs and kidneys) in both adults and children aged 2 years and older.
Moreover, it is indicated for moderate-to-severe pemphigus vulgaris, an autoimmune disorder that leads to painful blisters on the skin and mucous membranes.
Patients frequently ask about the price of Cytomab 100mg, and healthcare professionals may clarify how Cytomab 100mg functions—by specifically targeting and depleting certain B-cells that are responsible for abnormal immune responses or cancer proliferation, thus aiding in disease management.